These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12392767)

  • 1. Amyloid immunization in Alzheimer's disease: do we promote amyloid scavenging at the cost of inflammatory degeneration?
    Pasinetti GM; Ho L; Pompl P
    Neurobiol Aging; 2002; 23(5):665-6. PubMed ID: 12392767
    [No Abstract]   [Full Text] [Related]  

  • 2. Open peer commentary regarding Abeta immunization and CNS inflammation by Pasinetti et al.
    Das P; Golde TE
    Neurobiol Aging; 2002; 23(5):671-4; discussion 683-4. PubMed ID: 12392769
    [No Abstract]   [Full Text] [Related]  

  • 3. Amyloid immunotherapy-engendered CNS inflammation.
    Bowers WJ; Federoff HJ
    Neurobiol Aging; 2002; 23(5):675-6; discussion 683-4. PubMed ID: 12392770
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of neuroinflammation in Alzheimer disease.
    Graeber MB
    Neurogenetics; 1999 Sep; 2(3):135-6. PubMed ID: 10541585
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease.
    Morales I; Farías G; Maccioni RB
    Neuroimmunomodulation; 2010; 17(3):202-4. PubMed ID: 20134203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?
    Praticò D; Trojanowski JQ
    Neurobiol Aging; 2000; 21(3):441-5; discussion 451-3. PubMed ID: 10858591
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
    Patton RL; Kalback WM; Esh CL; Kokjohn TA; Van Vickle GD; Luehrs DC; Kuo YM; Lopez J; Brune D; Ferrer I; Masliah E; Newel AJ; Beach TG; Castaño EM; Roher AE
    Am J Pathol; 2006 Sep; 169(3):1048-63. PubMed ID: 16936277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein.
    Masumura M; Hata R; Nishimura I; Uetsuki T; Sawada T; Yoshikawa K
    Brain Res Mol Brain Res; 2000 Sep; 80(2):219-27. PubMed ID: 11038254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.
    Qiu Z; Gruol DL
    J Neuroimmunol; 2003 Jun; 139(1-2):51-7. PubMed ID: 12799020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates.
    Gandy S; Walker L
    Curr Opin Immunol; 2004 Oct; 16(5):607-15. PubMed ID: 15342007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamines and protein deposition in Parkinson's and Alzheimer's disease: old medicine, new targets.
    Bharath S; Andersen JK
    Rejuvenation Res; 2004; 7(2):92-4. PubMed ID: 15312295
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum and Alzheimer's disease: a Vexata Questio between uncertain data and a lot of imagination.
    Zatta P
    J Alzheimers Dis; 2006 Sep; 10(1):33-7. PubMed ID: 16988479
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters.
    Gruden MA; Davidova TB; Malisauskas M; Sewell RD; Voskresenskaya NI; Wilhelm K; Elistratova EI; Sherstnev VV; Morozova-Roche LA
    J Neuroimmunol; 2007 May; 186(1-2):181-92. PubMed ID: 17477976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy for Alzheimer's disease targeting Aβ].
    Tabira T
    Nihon Rinsho; 2016 Mar; 74(3):423-6. PubMed ID: 27025080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunization witha synthetic fragment 155-164 of neurotrophin receptor p75 prevents memory loss and decreases beta-amyloid level in mice with experimentally induced Alzheimer's disease].
    Vol'pina OM; Medvinskaia NI; Kamynina AV; Zaporozhskaia IaV; Aleksandrova IIu; Koroev DO; Samokhin AN; Volkova TD; Arsen'ev AS; Bobkova NV
    Bioorg Khim; 2014; 40(4):451-7. PubMed ID: 25898755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.
    Rosset MB; Lui G; Dansokho C; Chaigneau T; Dorothée G
    J Neuroinflammation; 2015 May; 12():95. PubMed ID: 25982697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives in immunotherapy of Alzheimer's disease].
    Rossi G
    Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.